Citius Oncology, Inc.
Citius Oncology develops targeted oncology therapies.
SCHEDULE 13G/ANov 16Latest SEC filing
Nov 4Latest story
November 2026
October 2026
August 2026
Citius Oncology develops targeted oncology therapies.
November 2026
October 2026
August 2026